Navigation Links
FDA Lifts Clinical Hold on Genta's Tesetaxel, a Leading Oral Taxane
Date:6/23/2008

dosing options when tesetaxel is used alone or in combination with other anticancer drugs. Preclinically, tesetaxel has demonstrated substantially higher activity against cell lines that were resistant to paclitaxel and docetaxel, since acquired resistance is not mediated by the multidrug-resistant p-glycoprotein.

As a late Phase 2 oncology product, tesetaxel has demonstrated anticancer activity in its initial clinical trials, and the drug has not been associated with the severe infusion reactions that are linked with other taxanes. Moreover, unlike other oral taxanes that are currently in clinical development, nerve damage has not been a prominent side effect of tesetaxel. Thus, the drug offers substantial opportunities to improve patient convenience, safety, and anticancer activity.

More than 250 patients worldwide have been treated with oral tesetaxel in Phase I and Phase 2 clinical trials. The major side-effect of tesetaxel in clinical trials has been myelosuppression, chiefly neutropenia. Due to the occurrence of severe neutropenia that led to fatal outcomes in several patients with advanced cancer, the drug was placed on clinical hold by FDA. Resumption of clinical trials was subject to the lifting of this clinical hold.

About Genta

Genta Incorporated is a biopharmaceutical company with a diversified product portfolio that is focused on delivering innovative products for the treatment of patients with cancer. Two major programs anchor the Company's research platform: DNA/RNA-based Medicines and Small Molecules. Genasense(R) (oblimersen sodium) Injection is the Company's lead compound from its DNA/RNA Medicines program. Genta is currently recruiting patients to the AGENDA Trial, a global Phase 3 trial of Genasense in patients with advanced melanoma. The leading drug in Genta's Small Molecule program is Ganite(R) (gallium nitrate injection), which the Company is exclusively marketing in the U.S. for treatment of symptomatic patients
'/>"/>

SOURCE Genta Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. PAREXEL Data Reveal A Record High Number of Clinical Trials Initiated
2. iCAD Initiates Clinical Study of Its Virtual Colonoscopy CAD in Partnership with ACR Image Metrix
3. Forest Laboratories Announces Positive Results from Phase III Clinical Studies of Ceftaroline for the Treatment of Complicated Skin and Skin Structure Infections
4. eRT Announces the Availability of the Suicidality Monitoring System(TM) For Clinical Trials
5. The Leukemia & Lymphoma Society and Memgen Collaborate on CLL Clinical Trial
6. Randomized Controlled Clinical Trial Shows Derma Sciences MEDIHONEY(TM) Eradicates MRSA From Chronic Venous Ulcers
7. Champions Biotechnology Begins Preclinical Development of Its Lead Oncology Drug Candidate
8. Cardinal Health Expands PET Nuclear Pharmacy Services to Support Clinical Drug Trials
9. Fox Chase Cancer Center and VisEn Medical Announce Program to Advance First Clinical Trials of Novel Fluorescence Molecular Imaging Technologies
10. Transdel Initiates Ketotransdel(TM) Phase 3 Clinical Program for Pain
11. Sunesis Pharmaceuticals Presents Data from Clinical Trials of Voreloxin (formerly SNS-595) in Patients with Acute Myeloid Leukemia at the 13th Congress of the European Hematology Association
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... July 24, 2014  IGI Laboratories, Inc. (NYSE MKT: IG), ... company, announced its financial results for the second quarter ended ... , Total revenues of $6.5 million in the second ... quarter in 2013 , Total revenues of $13.3 million ... of 78% over the same period in 2013 , ...
(Date:7/24/2014)... ANGELES , July 24, 2014 Many new ... they can do to ensure that their practice will be ... purchase the basic supplies they use the most can make ... and many dentists have recently discovered that purchasing discount ... loss. According to successful dentists across ...
(Date:7/24/2014)... N.C. , July 24, 2014 ... has signed an Agreement with Kineticos, a ... consulting company. Kineticos will support LSI Medience in ... sepsis management, to demonstrate utility in clinical trials. ... shown potential utility in diagnosis of sepsis, prognosis ...
Breaking Medicine Technology:IGI Laboratories Announces Second Quarter 2014 Results 2IGI Laboratories Announces Second Quarter 2014 Results 3IGI Laboratories Announces Second Quarter 2014 Results 4IGI Laboratories Announces Second Quarter 2014 Results 5IGI Laboratories Announces Second Quarter 2014 Results 6IGI Laboratories Announces Second Quarter 2014 Results 7Dental Supplies Online is Key to Dental Success...Really! 2LSI Medience Corporation and Kineticos Sign Agreement Related to the Presepsin Biomarker in Sepsis Management and Treatment 2
... 28, 2011  A 67-year-old man with Alzheimer,s disease is ... outside in near-freezing temperatures thanks to the quick action of ... wearable locator device. Robert Campbell was recovered ... He was located on Victory Boulevard, more than a mile ...
... LOS ANGELES, Feb. 28, 2011 InstaCare Corp. (OTC ... provider of direct to patient diabetes programs, a leading ... chronically ill, and a leading developer of revolutionary cell ... on Thursday, February 24, 2011, the Company filed a ...
Cached Medicine Technology:Staten Island Man Now Safe at Home Thanks to EmSeeQ® Locator Device 2Staten Island Man Now Safe at Home Thanks to EmSeeQ® Locator Device 3InstaCare Files Full Utility Patent for MD@Hand & MD@Work Technologies 2InstaCare Files Full Utility Patent for MD@Hand & MD@Work Technologies 3
(Date:7/25/2014)... Silver®Care , for the first time in the United ... kill oral bacteria and airborne bacteria from the bathroom that ... the most common and important device in the prevention of ... to constant contamination by bacteria found in the mouth and ... mouth than anywhere else in the human body, and some ...
(Date:7/24/2014)... a renowned wedding dress manufacturer and retailer, has recently ... . According to the company’s marketing specialist, all these ... prices, up to 59% off. The special offer will ... Most of the casual party dresses provided by iFitDress.com ... for special designs, delicate craftsmanship and affordable rates. Now, ...
(Date:7/24/2014)... [Brown University] The U.S. Preventive Services Task ... for people at high risk for cancer, but ... patients will have positive results on the screening ... testing. Many policymakers have expressed concern that this ... needlessly upset. A new study of National Lung ...
(Date:7/24/2014)... The Traffic and Leads Training Academy ... help users generate traffic and leads has just been ... throughout the internet marketing community. The excitement surrounding the ... Hendricks prompting a comprehensive review of the course. ... marketing will tell you, it can be quite challenging ...
(Date:7/24/2014)... Triangle Park, NC (PRWEB) July 24, 2014 ... elderly, ethnic minorities, and low-income households are disproportionately ... and public food safety net in the United ... International. , Under Section 743 of the Consolidated ... U.S. Department of Agriculture's Food and Nutrition Service ...
Breaking Medicine News(10 mins):Health News:Silver®Care’s New Silver Antibacterial Toothbrushes Naturally Kill Oral Germs 2Health News:Silver®Care’s New Silver Antibacterial Toothbrushes Naturally Kill Oral Germs 3Health News:2014 Casual Party Dresses for Chic Ladies Now at iFitDress.com 2Health News:Informed consent: False positives not a worry in lung cancer study 2Health News:Informed consent: False positives not a worry in lung cancer study 3Health News:Traffic And Leads Training Academy - Review Examining Jeff Johnson’s New IM Course Released 2Health News:Report: Vulnerable Populations Disproportionately Affected by Food Security, Despite Public Programs 2Health News:Report: Vulnerable Populations Disproportionately Affected by Food Security, Despite Public Programs 3
... Accompanies Manuscript in March IssueTAMPA, Fla., March 2 ... peginterferon alfa-2a and ribavirin in patients with chronic ... was published in the March issue of ... Gastroenterological Association Institute (AGA Institute). The study showed ...
... 2 /PRNewswire-FirstCall/ - Bioniche Life Sciences Inc. (TSX: ... announced that the Company has amended the maturity ... with Valens U.S. (formerly Laurus Master Funds). , ... to a near-term extension of this facility, originally ...
... 2 Cardiac Science Corporation (Nasdaq: CSCX ... rehabilitation, and informatics products, announced today that it will ... March 12, 2009 after the market close. The Company ... for 4:30 p.m. Eastern Time. During the call, ...
... APA,s Psychologically Healthy Workplace Awards, Ten Honored for ... of the economy can be felt across all ... during tough economic times reap rewards for employer ... (APA) at its Psychologically Healthy Workplace Awards ceremony ...
... uninsured and underinsured is destabilizing state,s health care safety net. Health ... , ... Detroit, Michigan (PRWEB) March 2, 2009 -- ... and destabilizing the state,s health care delivery system. More than one ...
... Drinking one glass of wine a day may lower ... a new study by the Kaiser Permanente Division of Research ... is a precursor to esophageal cancer, the nation,s fastest growing ... the last 30 years. , Barrett,s Esophagus affects 5 ...
Cached Medicine News:Health News:Study Showing Improved Virologic Response with Nitazoxanide in Chronic Hepatitis C Published in Gastroenterology 2Health News:Study Showing Improved Virologic Response with Nitazoxanide in Chronic Hepatitis C Published in Gastroenterology 3Health News:Study Showing Improved Virologic Response with Nitazoxanide in Chronic Hepatitis C Published in Gastroenterology 4Health News:Bioniche Revolving Credit Facility Maturity Date Amended 2Health News:Cardiac Science Schedules Fourth Quarter Earnings Release and Announces Conference Call 2Health News:Top Employers Find That in Tough Economic Times, a Healthy, Productive Workplace is More Important Than Ever 2Health News:Top Employers Find That in Tough Economic Times, a Healthy, Productive Workplace is More Important Than Ever 3Health News:Top Employers Find That in Tough Economic Times, a Healthy, Productive Workplace is More Important Than Ever 4Health News:Cover The Uninsured Week, March 22 - 28 in Michigan 2Health News:Cover The Uninsured Week, March 22 - 28 in Michigan 3Health News:Cover The Uninsured Week, March 22 - 28 in Michigan 4Health News:Drinking wine lowers risk of Barrett's esophagus, precursor to nation's fastest growing cancer 2Health News:Drinking wine lowers risk of Barrett's esophagus, precursor to nation's fastest growing cancer 3
Provides 30% more illumination, high light output for true tissue. Wide-angle viewing lens, sealed system for pneumatic otoscopy....
... The Shandon Cryotome FE and FSE are ... Thermo Electron. The microtome is outside of ... cleaning, as well as faster temperature adjustment. ... operation. Complete temperature controls on the main ...
A standard, durable and reliable indirect....
Designed to retain the desired curve during oral intubation....
Medicine Products: